These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The CCL20-CCR6 Axis in Cancer Progression. Kadomoto S; Izumi K; Mizokami A Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707869 [TBL] [Abstract][Full Text] [Related]
23. CCL20/CCR6 axis mediates macrophages to promote proliferation and migration of ESCs by blocking autophagic flux in endometriosis. Tan J; Xu T; Gou Y; Wang H; Liang Z; Cao Y; Wang H; Yu Y; Jiao N; Zhang Z Stem Cell Res Ther; 2022 Jul; 13(1):294. PubMed ID: 35841069 [TBL] [Abstract][Full Text] [Related]
24. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway. Liu X; Zhang A; Xiang J; Lv Y; Zhang X Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244 [TBL] [Abstract][Full Text] [Related]
25. The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis. Jiao X; Shu G; Liu H; Zhang Q; Ma Z; Ren C; Guo H; Shi J; Liu J; Zhang C; Wang Y; Gao Y J Histochem Cytochem; 2019 May; 67(5):299-308. PubMed ID: 30633620 [TBL] [Abstract][Full Text] [Related]
26. MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression. Zhu K; Pan Q; Zhang X; Kong LQ; Fan J; Dai Z; Wang L; Yang XR; Hu J; Wan JL; Zhao YM; Tao ZH; Chai ZT; Zeng HY; Tang ZY; Sun HC; Zhou J Carcinogenesis; 2013 Sep; 34(9):2071-9. PubMed ID: 23671131 [TBL] [Abstract][Full Text] [Related]
27. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma. Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637 [TBL] [Abstract][Full Text] [Related]
28. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2. Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369 [TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals. Perez S; Kaspi A; Domovitz T; Davidovich A; Lavi-Itzkovitz A; Meirson T; Alison Holmes J; Dai CY; Huang CF; Chung RT; Nimer A; El-Osta A; Yaari G; Stemmer SM; Yu ML; Haviv I; Gal-Tanamy M PLoS Genet; 2019 Jun; 15(6):e1008181. PubMed ID: 31216276 [TBL] [Abstract][Full Text] [Related]
30. Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis. Huang XX; McCaughan GW; Shackel NA; Gorrell MD Liver Int; 2007 Sep; 27(7):960-8. PubMed ID: 17696935 [TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma. Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133 [TBL] [Abstract][Full Text] [Related]
32. The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients. Zhang CY; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S Biomed Pharmacother; 2015 Feb; 69():242-8. PubMed ID: 25661365 [TBL] [Abstract][Full Text] [Related]
33. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice. Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627 [TBL] [Abstract][Full Text] [Related]
34. Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis. De Giorgi V; Buonaguro L; Worschech A; Tornesello ML; Izzo F; Marincola FM; Wang E; Buonaguro FM PLoS One; 2013; 8(2):e56153. PubMed ID: 23441164 [TBL] [Abstract][Full Text] [Related]
35. PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment. Liu Y; Wei D; Deguchi Y; Xu W; Tian R; Liu F; Xu M; Mao F; Li D; Chen W; Valentin LA; Deguchi E; Yao JC; Shureiqi I; Zuo X Gastric Cancer; 2023 Nov; 26(6):904-917. PubMed ID: 37572185 [TBL] [Abstract][Full Text] [Related]
36. Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas. Hsiao YW; Chiu LT; Chen CH; Shih WL; Lu TP Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31434354 [TBL] [Abstract][Full Text] [Related]
37. Disparity of Hepatocellular Carcinoma in Tumor Microenvironment-Related Genes and Infiltrating Immune Cells between Asian and Non-Asian Populations. Huang LH; Hsieh TM; Huang CY; Liu YW; Wu SC; Chien PC; Hsieh CH Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440448 [TBL] [Abstract][Full Text] [Related]
38. Robo1 promotes angiogenesis in hepatocellular carcinoma through the Rho family of guanosine triphosphatases' signaling pathway. Ao JY; Chai ZT; Zhang YY; Zhu XD; Kong LQ; Zhang N; Ye BG; Cai H; Gao DM; Sun HC Tumour Biol; 2015 Nov; 36(11):8413-24. PubMed ID: 26022159 [TBL] [Abstract][Full Text] [Related]
39. Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method. Lee SY; Song KH; Koo I; Lee KH; Suh KS; Kim BY Genomics; 2012 Jun; 99(6):347-54. PubMed ID: 22564472 [TBL] [Abstract][Full Text] [Related]